Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Silicon Mediated Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107428784A details a safer silicon-mediated CDI route for beta-lactamase inhibitor intermediates, offering significant supply chain and cost advantages.